This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of active pharmaceutical ingredients (APIs) and intermediates. Its structure, featuring a bromophenyl group and trifluoroethylamine moiety, makes it a valuable building block in the creation of compounds targeting neurological and psychiatric disorders. It is often employed in the development of ligands for receptors in the central nervous system, aiding in the study of conditions like depression, anxiety, and schizophrenia. Additionally, its chiral nature allows for the exploration of enantioselective interactions in drug design, enhancing the specificity and efficacy of therapeutic agents.